BioNTech SE (BNTX) Amortization (2018 - 2023)
BioNTech SE's Amortization history spans 6 years, with the latest figure at $21.7 billion for Q2 2023.
- On a quarterly basis, Amortization rose 20.7% to $21.7 billion in Q2 2023 year-over-year; TTM through Jun 2023 was $79.9 billion, a 51.65% increase, with the full-year FY2019 number at $198323.3, up 247.85% from a year prior.
- Amortization hit $21.7 billion in Q2 2023 for BioNTech SE, roughly flat from $21.8 billion in the prior quarter.
- Over the last five years, Amortization for BNTX hit a ceiling of $21.8 billion in Q1 2023 and a floor of -$133.7 million in Q4 2019.
- Historically, Amortization has averaged $8.0 billion across 5 years, with a median of $3.0 billion in 2021.
- Biggest five-year swings in Amortization: plummeted 150.57% in 2019 and later soared 5056.93% in 2021.
- Tracing BNTX's Amortization over 5 years: stood at -$133.7 million in 2019, then soared by 1359.66% to $1.7 billion in 2020, then soared by 510.09% to $10.3 billion in 2021, then surged by 80.26% to $18.5 billion in 2022, then increased by 17.06% to $21.7 billion in 2023.
- Business Quant data shows Amortization for BNTX at $21.7 billion in Q2 2023, $21.8 billion in Q1 2023, and $18.5 billion in Q3 2022.